Guardant Health

Guardant Health Q2 Losses Rise Amid Revenue Growth
Motley Fool
Thu, 08/8/24 - 11:09 am
Guardant Health
earnings
diagnostics
Medtech
FDA approves Guardant Health's blood-based cancer test
Reuters
Mon, 07/29/24 - 10:41 am
FDA
diagnostics
Guardant Health
colorectal cancer
Shield
Medtech
FDA advisers back approval for Guardant's blood-based cancer test
Reuters
Thu, 05/23/24 - 09:40 pm
Medtech
Guardant Health
FDA
colorectal cancer
diagnostics
FDA staff says Guardant's test may fail to detect some pre-cancerous tumors
Reuters
Tue, 05/21/24 - 11:12 am
diagnostics
Medtech
Guardant Health
colorectal cancer
FDA
Exact Sciences, Guardant rally after Freenome colorectal cancer test results
Tip Ranks
Wed, 04/3/24 - 11:19 am
Medtech
diagnostics
Freenome
EXACT Sciences
Guardant Health
colorectal cancer
liquid biopsy
A simple blood test can detect colorectal cancer early, study finds
NPR
Thu, 03/14/24 - 11:20 am
Guardant Health
diagnostics
Medtech
colorectal cancer
clinical trials
Guardant abandons cancer blood test trial early, restates confidence in product line
Medtech Dive
Wed, 09/6/23 - 11:50 am
Medtech
diagnostics
Guardant Health
colon cancer
Illumina & Guardant Settle Trade Secret Lawsuit
Medical Devices and Diagnostics Industry
Mon, 08/7/23 - 11:05 pm
Illumina
Guardant Health
legal
trade secrets
Guardant, Illumina Settle Patent Suit, Renew Long-Term Commercial Partnership
360Dx
Wed, 08/2/23 - 10:42 am
Guardant Health
Illumina
diagnostics
Medtech
legal
Guardant blood test detects 83% of colorectal cancer cases, but fewer in early stage
Medtech Dive
Thu, 05/11/23 - 10:59 am
Guardant Health
diagnostics
Medtech
colorectal cancer
Shield
clinical trials
Diagnostics companies turn to restructuring in bid to preserve cash: Goldman
Medtech Dive
Tue, 02/7/23 - 11:11 am
diagnostics
restructuring
Cue Health
GeneDx
Invitae
EXACT Sciences
Guardant Health
Guardant DNA blood test finds 83% of colorectal cancers in trial, shares fall 35%
Reuters
Thu, 12/15/22 - 11:13 pm
Guardant Health
DNA
diagnostics
colorectal cancer
EXACT Sciences
Big medtechs’ efficiency starts to recover from Covid
EP Vantage
Mon, 11/21/22 - 10:01 am
Medtech
surgeries
COVID-19
pandemic
Intuitive Surgical
Veracyte
Castle Biosciences
RA Medical
Guardant Health
Abbott Labs
Alcon
Boston Scientific
Baxter
Becton Dickinson
Edwards Lifesciences
ResMed
Philips
Medtronic
Stryker
Zimmer Biomet
7 of the Most Shocking M&A Rumors in Medtech
Medical Devices and Diagnostics Industry
Thu, 08/4/22 - 06:38 pm
Medtech
M&A
DexCom
Insulet
Medtronic
LivaNova
Baxter
Hill-Rom
Stryker
Boston Scientific
Illumina
Grail
Guardant Health
NeoGenomics
Smith & Nephew
Despair engulfs smaller device companies
EP Vantage
Fri, 07/15/22 - 10:36 am
devices
Medtech
Haemonetics
Teladoc Health
Ambu
Natera
Tandem Diabetes Care
Guardant Health
Freenome aims to take on the big beasts
EP Vantage
Wed, 04/13/22 - 10:36 am
Freenome
liquid biopsies
colorectal cancer
diagnostics
Medtech
Guardant Health
Illumina sues Guardant CEOs over trade secrets, sparking counterblast against 'retaliatory' lawsuit
Medtech Dive
Fri, 03/18/22 - 10:46 am
Illumina
Guardant Health
trade secrets
legal
M&A
Grail
Liquid biopsy developers take aim at colorectal cancer
EP Vantage
Fri, 02/11/22 - 10:09 am
liquid biopsies
Medtech
diagnostics
colorectal cancer
EXACT Sciences
Guardant Health
Natera
A bad year to be an American medtech
EP Vantage
Thu, 01/6/22 - 10:56 am
devices
Medtech
Europe
EXACT Sciences
Getinge
Guardant Health
Penumbra
Philips
Siemens Healthineers
Sonova
Straumann
Teladoc Health
Teleflex
Guardant steps into a new arena
EP Vantage
Tue, 06/22/21 - 10:57 am
Guardant Health
liquid biopsy
immunotherapy
diagnostics

Pages